Q-omics provides the consensus-scored C13orf46 profile across patient tissues and cancer cell-line models. Additionally, C13orf46 RNA expression shows 10,774 significant protein co-abundance associations, with the highest sampling consensus in LUAD.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Premium analyses for C13orf46 — synthetic lethality, tumor antigen, and pembrolizumab response.

View premium →

Cross-omics associations

This table shows molecular features associated with C13orf46 in patient tissues and cancer cell lines. In patient samples, C13orf46 shows the broadest associations at the RNA and protein expression levels, with LUAD recurring as the lineage with the largest associated feature set. In cancer cell lines, C13orf46 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in BONE.

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
Protein (mass-spec)	10,774	LUAD (4582)	view →
Function (mass-spec)	835	LUAD (279)	view →

Associated data type	Strength (# associated data)	Lineage of highest associated data
▼RNA
RNA	9,701	BONE (3345)	view →
Function (RNA)	4,151	BONE (1766)	view →